Taro Company Profile

✉ Email this page to a colleague

TARO has two hundred and fifty-three approved drugs.

There are eight US patents protecting TARO drugs. There are four tentative approvals on TARO drugs.

There are thirty-one patent family members on TARO drugs in twelve countries and one hundred and seventy-three supplementary protection certificates in fourteen countries.

International Patents:	31
US Patents:	8
Tradenames:	133
Ingredients:	116
NDAs:	253
Patent Litigation for Taro:	See patent lawsuits for Taro
PTAB Cases with Taro as petitioner:	See PTAB cases with Taro as petitioner

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Taro	FLUPHENAZINE HYDROCHLORIDE	fluphenazine hydrochloride	TABLET;ORAL	215674-003	Apr 14, 2022	AB	RX	No	No		⤷ Try a Trial				⤷ Try a Trial
Taro	TERCONAZOLE	terconazole	SUPPOSITORY;VAGINAL	077553-001	Mar 9, 2007	AB	RX	No	No		⤷ Try a Trial				⤷ Try a Trial
Taro	CETIRIZINE HYDROCHLORIDE HIVES RELIEF	cetirizine hydrochloride	TABLET;ORAL	078072-004	Jul 22, 2009		OTC	No	No		⤷ Try a Trial				⤷ Try a Trial
Taro	CARVEDILOL	carvedilol	TABLET;ORAL	077780-003	Sep 5, 2007	AB	RX	No	No		⤷ Try a Trial				⤷ Try a Trial
Taro	MELOXICAM	meloxicam	TABLET;ORAL	078102-002	Nov 7, 2006	AB	RX	No	No		⤷ Try a Trial				⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Taro	FLO-PRED	prednisolone acetate	SUSPENSION;ORAL	022067-002	Jan 17, 2008	6,656,482	⤷ Try a Trial
Taro	FLO-PRED	prednisolone acetate	SUSPENSION;ORAL	022067-001	Jan 17, 2008	5,881,926	⤷ Try a Trial
Taro	TOPICORT	desoximetasone	SPRAY;TOPICAL	204141-001	Apr 11, 2013	5,990,100	⤷ Try a Trial
Taro	PLIAGLIS	lidocaine; tetracaine	CREAM;TOPICAL	021717-001	Jun 29, 2006	5,919,479	⤷ Try a Trial
Taro	FLO-PRED	prednisolone acetate	SUSPENSION;ORAL	022067-002	Jan 17, 2008	6,071,523	⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Drugname	Dosage	Strength	Tradename	Submissiondate
➤ Subscribe	Topical Spray	0.25%	➤ Subscribe	2013-12-18
➤ Subscribe	Topical Lotion	0.5%	➤ Subscribe	2011-03-16

Subscribe to access the full database, or Try a Trial
Country	Patent Number	Estimated Expiration
Canada	2616112	⤷ Try a Trial
Australia	2006278620	⤷ Try a Trial
World Intellectual Property Organization (WIPO)	2007005988	⤷ Try a Trial
China	102834096	⤷ Try a Trial
World Intellectual Property Organization (WIPO)	2011088333	⤷ Try a Trial
>Country	>Patent Number	>Estimated Expiration

Subscribe to access the full database, or Try a Trial
Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
0162036	C300028	Netherlands	⤷ Try a Trial	PRODUCT NAME: LEVETIRACETAM; REGISTRATION NO/DATE: EU/1/00/146/001 - EU/1/00/146/026 20000929
0328535	96C0021	Belgium	⤷ Try a Trial	PRODUCT NAME: LANSOPRAZOLE + CLARITHROMYCINE + METRONIDAZOLE; REGISTRATION NO/DATE IN FRANCE: K 27 17033R DU 19960209; REGISTRATION NO/DATE AT EEC: K 27 17033R DU 19960209
2380576	2020/043	Ireland	⤷ Try a Trial	PRODUCT NAME: DEOXYCHOLIC ACID SODIUM SALT; NAT REGISTRATION NO/DATE: PA2103/003/001 20170602; FIRST REGISTRATION NO/DATE: SE/H/1547/001/DC 20160729
2822954	2018/031	Ireland	⤷ Try a Trial	PRODUCT NAME: BICTEGRAVIR OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, IN PARTICULAR BICTEGRAVIR SODIUM.; REGISTRATION NO/DATE: EU/1/18/1289 20180625
0058146	2001C/045	Belgium	⤷ Try a Trial	PRODUCT NAME: DICHLORHYDRATE DE LEVOCETIRIZINE; NAT RER. NO/DATE: 194 IS 90 F3 20011022; FIRST REG.: DE 49903.00.00 20010103
>Patent Number	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration	>SPC Description

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.